Matrix metalloproteinase-9 silencing by RNA interference promotes the adhesive-invasive switch in HT1080 human fibrosarcoma cells

Clinical Laboratory

Volumn 58, Issue 3-4, 2012, Pages 313-322

  Zhu, Xishan ^a   Tai, Weiping ^a   Shi, Wei ^a   Song, Yuguang ^a   Zhang, Hongmei ^a   An, Guangyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adhesive invasive switch; Gene target therapy; HT1080 human fibrosarcoma cells; Matrix metalloproteinase 9 (MMP 9); RNA interference

Indexed keywords

DOUBLE STRANDED RNA; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME INHIBITION; FIBROSARCOMA; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; FIBROSARCOMA; GENE SILENCING; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM METASTASIS; RNA INTERFERENCE;

MUS; MUS MUSCULUS;

EID: 84859875708     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barnes DJ, Melo JV. Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 2006;5:2862-6. (Pubitemid 44953936)
2. Jørgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL. Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+CML cells. Blood 2007;109:4016-9. (Pubitemid 46641755)
3. Fridman R, Toth M, Chvyrkova I, Meroueh S, Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003;22:153-66. (Pubitemid 36561055)
4. Sanceau J, Truchet S, Bauvois B. Matrix Metalloproteinase-9 Silencing by RNA interference triggers the migratory-adhesive switch in Ewing's Sarcoma Cells. J Biol Chem 2003;278(38):36537-46. (Pubitemid 37139984)
5. Stefanidakis M, Koivunen E. Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression. Blood 2006;108:1441-50. (Pubitemid 44316107)
6. Paupert J, Mansat-Dc Mas V, Demur C. Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features. Cell Cycle 2008 Apr 15;7(8):1047-53. Epub 2008 Jan 18.
7. Liu WH, Tang NN, Zhang QD. Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rates? Chin Med J (Engl) 2009 Jan 20;122(2):199-204.
8. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 1974 Apr;33(4):1027-33.
9. Lewis ID, McDiarmid LA, Samels LM, To LB, Hughes TP. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells. Blood 1998;91:630-40. (Pubitemid 28053388)
10. Li LH, Baek IK, Kim JH, et al. Methanol extract of Elaeagnus glabra, a Korean medicinal plant, inhibits HT1080 tumor cell invasion. Oncol Rep 2009 Feb;21(2):559-63.
11. Jin F, Zhai Q, Qiu L, et al. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant 2008 Nov;42(9):581-8. Epub 2008 Aug 4.
12. Leonardo CC, Eakin AK, Ajmo JM, et al. Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injure after hypoxia-ischemia in the neonatal rat. J Neuroinflammation 2008 Aug 11;5:34.
13. Adibhatla RM, Hatcher JF. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 2008 Jun;7(3):243-53. Review.
14. Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 2008 Feb 27;82(9-10):467-76. Epub 2007 Dec 27.
15. Hessel MH, Bleckcr GB, Bax JJ, et al. Reverse ventricular remodeling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels. Eur J Heart Fail 2007 Oct;9(10):1058-63. Epub 2007 Aug 28.
16. Yang K, Liu L, Zhang T, et al. TGF-beta1 transgenic mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the lung tissue. J Huazhong Univ Sci Technolog Med Sci 2006;26(3):301-4.
17. Gunduz K, Demireli P, Inanir I, Nese NJ. Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in liehen planus. Cutan Pathol 2006 Aug;33(8):545-50. (Pubitemid 44213855)
18. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement. Amino Acids 2007 Jan;32(1):109-14. Epub 2006 Aug 2.
19. Mitra A, Chakrabarti J, Banerji A, Das S, Chatterjee A. Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2. J Cancer Res Clin Oncol 2006 Aug;132(8):505-13. Epub 2006 Apr 26.
20. Kim KC, Lee CH. MAP kinase activation is required for the MMP-9 induction by TNF-stimulation. Arch Pharm Res 2005 Nov;28(11):1257-62.
21. Desrosiers RR, Rivard ME, Grundy PE, Annabi B. Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr Blood Cancer 2006 Jan;46(1):40-9. (Pubitemid 41779316)
22. Dalton SJ, Mitchell DC, Whiting CV, Tarlton JF. Abnormal extracellular matrix metabolism in chronically ischemic skin: a mechanism for dermal failure in leg ulcers. J Invest Dermatol 2005 Aug;125(2):373-9. (Pubitemid 41648172)
23. Lin M, Jackson P, Tester AM, et al. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am J Pathol 2008 Jul;173(1):144-53. Epub 2008 Jun 13.
24. Yang K, Palm J, König J, et al. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury. Int J Radiat Biol 2007 Oct;83(10):665-76. (Pubitemid 47345865)
25. Sang-Oh Yoon, Sejeong Shin, Ho-Jae Lee. Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinosito 3 kinase/ Akt dependent matrix metalloproteinase-9 expression. Mol Cancer Ther 2006;Nov, 5(11):344-9.
26. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008,267(1):133-64.
27. Zhang B, Liu R, Shi D, et al. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell production. Blood 2009 Jan 1;113(1):46-57. Epub 2008 Oct 2.
28. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-25.
29. Guo H, Fang B, Zhao RC. Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells. Exp Hemato .2003;31:650-8. (Pubitemid 36808808)
30. Lu Y, Wahl LM. Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKK/NF-κB pathway. J Leuk Bio 2005;78:259-65. (Pubitemid 40979965)
31. Shawn D, Pelletier, Daniel S. et al. Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Blood 2004;104:2163-71.
32. Martin-Henao GA, Quiroga R, Sureda A, et al. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Haematologica 2000;85:139-46. (Pubitemid 30366656)
33. Wertheim JA, Forsythe K, Druker BJ, et al. BCR-ABL-induced adhesion defects are tyrosine kinase-independent. Blood 2002 Jun 1;99(11):4122-30.